» Articles » PMID: 35639688

Engineering Nonphotosynthetic Carbon Fixation for Production of Bioplastics by Methanogenic Archaea

Overview
Specialty Science
Date 2022 May 31
PMID 35639688
Authors
Affiliations
Soon will be listed here.
Abstract

The conversion of CO2 to value-added products allows both capture and recycling of greenhouse gas emissions. While plants and other photosynthetic organisms play a key role in closing the global carbon cycle, their dependence on light to drive carbon fixation can be limiting for industrial chemical synthesis. Methanogenic archaea provide an alternative platform as an autotrophic microbial species capable of non-photosynthetic CO2 fixation, providing a potential route to engineered microbial fermentation to synthesize chemicals from CO2 without the need for light irradiation. One major challenge in this goal is to connect upstream carbon-fixation pathways with downstream biosynthetic pathways, given the distinct differences in metabolism between archaea and typical heterotrophs. We engineered the model methanogen, Methanococcus maripaludis, to divert acetyl-coenzyme A toward biosynthesis of value-added chemicals, including the bioplastic polyhydroxybutyrate (PHB). A number of studies implicated limitations in the redox pool, with NAD(P)(H) pools in M. maripaludis measured to be <15% of that of Escherichia coli, likely since methanogenic archaea utilize F420 and ferredoxins instead. Multiple engineering strategies were used to precisely target and increase the cofactor pool, including heterologous expression of a synthetic nicotinamide salvage pathway as well as an NAD+-dependent formate dehydrogenase from Candida boidinii. Engineered strains of M. maripaludis with improved NADH pools produced up to 171 ± 4 mg/L PHB and 24.0 ± 1.9% of dry cell weight. The metabolic engineering strategies presented in this study broaden the utility of M. maripaludis for sustainable chemical synthesis using CO2 and may be transferable to related archaeal species.

Citing Articles

Multi-scale reactor designs extend the physical limits of fixation.

Akbari A, Palsson B bioRxiv. 2024; .

PMID: 39257791 PMC: 11383689. DOI: 10.1101/2024.08.28.610213.


An improved CRISPR and CRISPR interference (CRISPRi) toolkit for engineering the model methanogenic archaeon Methanococcus maripaludis.

Du Q, Wei Y, Zhang L, Ren D, Gao J, Dong X Microb Cell Fact. 2024; 23(1):239.

PMID: 39227830 PMC: 11373211. DOI: 10.1186/s12934-024-02492-0.


Extremophiles in a changing world.

Cowan D, Albers S, Antranikian G, Atomi H, Averhoff B, Basen M Extremophiles. 2024; 28(2):26.

PMID: 38683238 PMC: 11058618. DOI: 10.1007/s00792-024-01341-7.


Microbial electrosynthesis: opportunities for microbial pure cultures.

Harnisch F, Deutzmann J, Boto S, Rosenbaum M Trends Biotechnol. 2024; 42(8):1035-1047.

PMID: 38431514 PMC: 11310912. DOI: 10.1016/j.tibtech.2024.02.004.


Editorial: The methane moment - Cross-boundary significance of methanogens: Preface.

Lyu Z, Rotaru A, Pimentel M, Zhang C, Rittmann S Front Microbiol. 2022; 13:1055494.

PMID: 36504803 PMC: 9731359. DOI: 10.3389/fmicb.2022.1055494.


References
1.
Blaut M . Metabolism of methanogens. Antonie Van Leeuwenhoek. 1994; 66(1-3):187-208. DOI: 10.1007/BF00871639. View

2.
Bar-Even A, Noor E, Milo R . A survey of carbon fixation pathways through a quantitative lens. J Exp Bot. 2011; 63(6):2325-42. DOI: 10.1093/jxb/err417. View

3.
Hendrickson E, Kaul R, Zhou Y, Bovee D, Chapman P, Chung J . Complete genome sequence of the genetically tractable hydrogenotrophic methanogen Methanococcus maripaludis. J Bacteriol. 2004; 186(20):6956-69. PMC: 522202. DOI: 10.1128/JB.186.20.6956-6969.2004. View

4.
Khosla C, Keasling J . Metabolic engineering for drug discovery and development. Nat Rev Drug Discov. 2003; 2(12):1019-25. DOI: 10.1038/nrd1256. View

5.
Ling C, Qiao G, Shuai B, Olavarria K, Yin J, Xiang R . Engineering NADH/NAD ratio in Halomonas bluephagenesis for enhanced production of polyhydroxyalkanoates (PHA). Metab Eng. 2018; 49:275-286. DOI: 10.1016/j.ymben.2018.09.007. View